Two new species of Gieysztoria (Platyhelminthes, Rhabdocoela, Dalyelliidae) from a freshwater artificial lake in Shenzhen, China.

Two new species of the "Aequales" of genus Gieysztoria were collected and described from an artificial lake on the Shenzhen University campus. Gieysztoria bimaculata n. sp., is distinguished based on two groups clavate pigmentations dorsally between the pharynx and intestine, and has a sclerotic stylet comprising a proximal girdle with 40-46 distal dagger-shape spines, thus has the maximum number of spines within "Aequales" group. Gieysztoria guangdongensis n. sp. has a sclerotic stylet with a proximal girdle and 18 distal blade-shaped spines. Comparison with similar species based mainly on stylet morphology suggests that Gieysztoria bimaculata n. sp. and Gieysztoria guangdongensis n. sp. are apparently different from the known species of Gieysztoria in this moment. In addition, the stability of the amount of distal spines of "Aequales" species is briefly discussed.

Synergistic effect of drug/antibiotic-impregnated micro/nanohybrid mesoporous bioactive glass/calcium phosphate composite bone cement on antibacterial and osteoconductive activities.

Calcium phosphate bone cements (CPC) can be used in minimally invasive surgery because of their injectability, and they can also be used to repair small and irregular bone defects. This study aimed to release the antibiotic gentamicin sulfate (Genta) to reduce tissue inflammation and prevent infection in the early stages of bone recovery. Subsequently, the sustained release of the bone-promoting drug ferulic acid (FA) mimicked the response of osteoprogenitor D1 cells interaction, thereby accelerating the healing process of the overall bone repair. Accordingly, the different particle properties of micro-nano hybrid mesoporous bioactive glass (MBG), namely, micro-sized MBG (mMBG) and nano-sized MBG (nMBG), were explored separately to generate different dose releases in MBG/CPC composite bone cement. Results show that nMBG had better sustained-release ability than mMBG when impregnated with the same dose. When 10 wt% of mMBG hybrid nMBG and composite CPC were used, the amount of MBG slightly shortened the working/setting time and lowered the strength but did not hinder the biocompatibility, injectability, anti-disintegration, and phase transformation of the composite bone cement. Furthermore, compared with 2.5wt%Genta@mMBG/7.5 wt% FA@nMBG/CPC, 5wt.%Genta@mMBG/5wt.%FA@nMBG/CPC exhibited better antibacterial activity, better compressive strength, stronger mineralization of osteoprogenitor cell, and similar 14-day slow-release trend of FA. The MBG/CPC composite bone cement developed can be used in clinical surgery to achieve the synergistic sustained release of antibacterial and osteoconductive activities.